SPEAKERS
Tina, Associate HR director of talent acquisition, Eli Lilly China
Tina currently serves as the Associate HR director of talent acquisition of Eli Lilly China and responsible for formulating and implementing Eli Lily China's talent acquisition strategy to support the company's business development and enhance organizational capacity. She joined Eli Lilly China in early 2013 and served as the human resources strategic partner. Before joined Eli Lilly China, she has served in Unilever, Nokia, Allianz and other multinational Fortune 500 companies. She have rich experience in many HR module such as talent acquisition, talent development, business partners, training system, employee communication etc. She have got MBA degree from China Europe International Business School and Bachelor degree of Computer Science and Technology from University of Science and Technology of China.
About Lilly
Lilly is a global health care leader that unites caring with discovery to make life better for people around the world. Based in Indianapolis, Indiana, Lilly conducts clinical research in more than 55 countries and markets products in 125. Lilly first established a presence in China in 1918 and has been expanding in the country since the early 1990s. Today, there are 4,000 Lilly employees in China – more than in any other country outside the U.S. Lilly products that treat infection, diabetes, cancer, diseases of the central nervous system, and other conditions helped an estimated 12 million Chinese patients in 2013. Lilly China is based in Shanghai, with offices in Beijing and in many provinces. Lilly has two manufacturing facilities in Suzhou, focusing on diabetes medicines, antibiotics, and central nervous system medicines, and a diabetes research center in Shanghai. Lilly is the first global pharmaceutical company to create a venture capital fund focused on China and has a history of collaborations with companies and universities in China. Lilly’s goal is to become a corporate citizen that is “In China, For China.” In March 2011, Lilly China received a “Special Contribution Award” from the Ministry of Health (MoH) for Lilly’s ongoing efforts to fight multidrug-resistant tuberculosis and for its close collaboration with the MoH and Chinese communities.